tumorigenesis
|
• starting from 4 months of age, mutants present with highly metastatic tumors originating in the adrenal medulla or sympathetic ganglia
• metastasis into liver, lungs, and para-aortic lymph nodes
|
neuroblastoma
(
J:54269
)
|
• starting from 4 months of age, mutants present with highly metastatic tumors originating in the adrenal medulla or sympathetic ganglia that resemble human infant neuroblastoma
• tumor incidence is 18%
• most tumors typically are bilateral adrenal tumors with multiple metastatic nodules in liver, lungs, and para-aortic lymph nodes
|
|
• most tumors typically are bilateral adrenal tumors with multiple metastatic nodules in liver, lungs, and para-aortic lymph nodes
|
mortality/aging
|
• some mutants die from intra-abdominal bleeding from spontaneously ruptured, highly vascularized adrenal tumors
|
immune system
|
• 4-week old mutants do not have measurable levels of antibodies against SV40 Tag, but by 5 months of age, they show a humoral immune response against the transgene product, indicating a lack of immunological tolerance to Tag
• adrenal glands with no evidence of tumors show lymphocytic infiltrations, signs of medullary cell destruction and hemorrhagic areas at the cortico-medullary border
|
Mouse Models of Human Disease |
OMIM ID | Ref(s) | |
| Neuroblastoma, Susceptibility to | 256700 | J:54269 | |
